ABVC BioPharma, Inc. (ABVC)
0.9801
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
1.01
+0.03
(+3.05%)
After-Hours: 20:00
ABVC BioPharma Market Cap : 25.25M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 25.25M |
| September 10, 2026 | 25.15M |
| September 09, 2026 | 24.99M |
| September 08, 2026 | 27.31M |
| September 04, 2026 | 24.74M |
| September 03, 2026 | 25.77M |
| September 02, 2026 | 22.28M |
| September 01, 2026 | 21.27M |
| August 31, 2026 | 22.10M |
| August 28, 2026 | 21.39M |
| August 27, 2026 | 20.50M |
| August 26, 2026 | 18.32M |
| August 25, 2026 | 20.61M |
| August 24, 2026 | 21.64M |
| August 21, 2026 | 23.14M |
| August 20, 2026 | 23.14M |
| August 19, 2026 | 24.35M |
| August 18, 2026 | 22.53M |
| August 17, 2026 | 22.10M |
| August 14, 2026 | 23.40M |
| August 13, 2026 | 24.95M |
| August 12, 2026 | 24.97M |
| August 11, 2026 | 25.62M |
| August 10, 2026 | 24.71M |
| August 07, 2026 | 26.53M |
| Date | Value |
|---|---|
| August 06, 2026 | 26.53M |
| August 05, 2026 | 26.27M |
| August 04, 2026 | 27.83M |
| August 03, 2026 | 27.05M |
| July 31, 2026 | 26.27M |
| July 30, 2026 | 28.09M |
| July 29, 2026 | 26.27M |
| July 28, 2026 | 27.57M |
| July 27, 2026 | 26.53M |
| July 24, 2026 | 29.91M |
| July 23, 2026 | 31.21M |
| July 22, 2026 | 30.69M |
| July 21, 2026 | 31.99M |
| July 20, 2026 | 31.21M |
| July 17, 2026 | 32.51M |
| July 16, 2026 | 31.47M |
| July 15, 2026 | 33.29M |
| July 14, 2026 | 34.85M |
| July 13, 2026 | 35.11M |
| July 10, 2026 | 39.27M |
| July 09, 2026 | 37.71M |
| July 08, 2026 | 52.54M |
| July 07, 2026 | 52.54M |
| July 06, 2026 | 49.42M |
| July 02, 2026 | 46.81M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 279.17M |
| Perspective Therapeutics, Inc. | 320.58M |
| MiMedx Group, Inc. | 665.96M |
| Abbott Laboratories | 176.41B |
| AngioDynamics, Inc. | 636.77M |
Market Cap Related Metrics
| PEG Ratio | -0.0794 |
| Price to Book Value | 2.455 |
| Price | 0.9801 |
| Earnings Yield | -29.36% |
| PEGY Ratio | -0.0794 |